Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- ENGNW
- Price
- 3.69
- Stock movement up
- +0.66 (21.58%)
- Company name
- enGene Holdings Inc. Warrants
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Market cap
- -
- Ent value
- 3.61M
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- -
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ENGNW does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | - |
| EPS (TTM) | -1.28 |
| FCF per share (TTM) | -1.96 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | -509.00K |
| Operating income (TTM) | -9.02M |
| Net income (TTM) | -65.67M |
| EPS (TTM) | -1.28 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 50.15M |
| Net receivables | 2.23M |
| Total current assets | 201.39M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 12.30M |
| Total assets | 221.47M |
| Accounts payable | 6.69M |
| Short/Current long term debt | 31.80M |
| Total current liabilities | 31.98M |
| Total liabilities | 53.76M |
| Shareholder's equity | 167.71M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -99.24M |
| Capital expenditures (TTM) | 1.49M |
| Free cash flow (TTM) | -100.72M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -39.16% |
| Return on Assets | -29.65% |
| Return on Invested Capital | -34.02% |
| Cash Return on Invested Capital | -52.18% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 3.30 |
| Daily high | 3.72 |
| Daily low | 3.19 |
| Daily Volume | 28K |
| All-time high | 6.38 |
| 1y analyst estimate | - |
| Beta | -0.27 |
| EPS (TTM) | -1.28 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ENGNW | S&P500 | |
| Current price drop from All-time high | -42.16% | -0.89% |
| Highest price drop | -91.82% | -19.00% |
| Date of highest drop | 9 Apr 2025 | 8 Apr 2025 |
| Avg drop from high | -79.24% | -2.49% |
| Avg time to new high | - | 6 days |
| Max time to new high | 248 days | 89 days |
COMPANY DETAILS
Marketcap
-
Marketcap category
Small-cap
Description
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. enGene Holdings Inc. is based in Montreal, Canada.
Employees
81
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner